Special Issue "Pharmacogenomics: Precision Medicine and Drug Response"
Deadline for manuscript submissions: closed (10 January 2022) | Viewed by 19997
2. Forensic Genetics Laboratoty, Department of Biomedicine and Prevention, Tor Vergata University, 00133 Rome, Italy
Interests: forensic genetics; genetic counselling; human identification; neurogenetics; prenatal and postnatal genetic diagnosis
Special Issues, Collections and Topics in MDPI journals
Special Issue in Genes: Molecular Genetics of Neurodegenerative Diseases and Neuromuscular Diseases
The advances in disease treatment have allowed the development of new therapeutic approaches. Over the years, many therapies have shown different efficacy profiles, supporting the development of precision medicine. Several pharmacogenomic approaches have been used to individualize treatments, optimizing dosage and preventing adverse effects. With the recent development of new high-throughput technologies and massive parallel sequencing, it is now possible to test the entire human genome to reveal positive associations between specific variations and the response to drugs in terms of efficacy and safety. Although numerous associations have been published, the translation to clinical practice in some areas has been minimal. A notable exception to this is the oncological field.
This Special Issue aims to curate available practical information in the pharmacogenomic domain to promote the translation of research data into precision medical protocols. Particular attention will be paid to new bioinformatic approaches to the interpretation of omic data and to research advances in populations that up to this point have little study data. At the same time, drug repurposing approaches will be encouraged to promote alternative applications of drugs with existing approval for use. This Special Issue of Genes will highlight recent advances in the field, and innovations in the use of omic data in the treatment of human diseases. Clinical and molecular studies, as well as reviews, will be considered for publication in this Issue.
Prof. Dr. Emiliano Giardina
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Drug Repurposing
- Precision Medicine
- Drug response
- Personalized therapies